Half Year 2019 Idorsia Ltd Earnings Call Transcript
Dear ladies and gentlemen, welcome to the Idorsia Conference Call regarding the Presentation of the Half Year Financial Results 2019. At our customer's request, this conference will be recorded. (Operator Instructions)
May I now hand you over to Andrew Weiss, who will lead you through this conference. Please go ahead.
Thank you, Angela. Good morning, good afternoon, everyone, and welcome to our call today. We're here gathered to discuss the first half results published this morning at 7 a.m. Central European standard time.
With me on the call are our CEO, Jean-Paul Clozel; our CFO, André Muller; and Guy Braunstein, Head of Global Clinical Development. He is here to discuss with us the data presented at San Antonio on daridorexant, our dual orexin receptor antagonist.
Next slide, please. Before we jump in, I need to remind everyone that we will be making forward-looking statements, and that there are risks and opportunities there in investing in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |